| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
12,760 |
3,087 |
$367K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
12,034 |
2,726 |
$96K |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
9,516 |
2,045 |
$37K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
633 |
255 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,046 |
384 |
$2K |
| 80053 |
Comprehensive metabolic panel |
535 |
206 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
338 |
13 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
98 |
35 |
$1K |
| 80061 |
Lipid panel |
315 |
122 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
423 |
140 |
$654.90 |
| 84443 |
Thyroid stimulating hormone (TSH) |
88 |
30 |
$299.45 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
114 |
39 |
$294.23 |
| 80164 |
|
35 |
14 |
$132.54 |
| 81003 |
|
131 |
56 |
$127.50 |
| 87109 |
|
20 |
12 |
$105.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
32 |
17 |
$40.00 |
| 83037 |
|
57 |
28 |
$0.00 |